P

Inventor

CROOKS PETER A

US54 patents
⚠️ This page may combine multiple inventors who share the name “CROOKS PETER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV KENTUCKY RES FOUND

18 patents
US5691365ANov 25, 1997

Nicotinic receptor antagonists in the treatment of neuropharmacological disorders

UNIV KENTUCKY RES FOUND52 citations95
US6087376AJul 11, 2000

Use of lobeline compounds in the treatment of central nervous system diseases and pathologies

UNIV KENTUCKY RES FOUND28 citations92
US5830904ANov 3, 1998

Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders

UNIV KENTUCKY RES FOUND24 citations92
US5681964AOct 28, 1997

Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents

UNIV KENTUCKY RES FOUND79 citations92
US6765019B1Jul 20, 2004

Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids

UNIV KENTUCKY RES FOUND16 citations91
US5552440ASep 3, 1996

Use of L-canavanine as a chemotherapeutic agent for the treatment of pancreatic cancer

UNIV KENTUCKY RES FOUND20 citations89
US6403602B1Jun 11, 2002

Morphine-6-sulfate analogues and their use for the treatment of pain

UNIV KENTUCKY RES FOUND18 citations76
US5776957AJul 7, 1998

Nornicotine enantiomers for use as a treatment for dopamine related conditions and disease states

UNIV KENTUCKY RES FOUND17 citations75
US6503922B2Jan 7, 2003

Bridged nicotine compounds for use in the treatment of CNS pathologies

UNIV KENTUCKY RES FOUND7 citations71
US6455543B1Sep 24, 2002

Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies

UNIV KENTUCKY RES FOUND6 citations71
US5859295AJan 12, 1999

Canavanine analogs and their use as chemotherapeutic agents

UNIV KENTUCKY RES FOUND7 citations70
US6218434B1Apr 17, 2001

Use of the naturally-occurring quinones thymoquinone and dithymoquinone as antineoplastic and cytotoxic agents

UNIV KENTUCKY RES FOUND13 citations68
US6943177B2Sep 13, 2005

Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies

UNIV KENTUCKY RES FOUND4 citations60
US7816407B2Oct 19, 2010

Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders

UNIV KENTUCKY RES FOUND4 citations55
US6703406B2Mar 9, 2004

2,6-disubstituted piperidines as modulators of nicotinic acetylcholine receptor mediated neurotransmitter release, uptake and storage

UNIV KENTUCKY RES FOUND5 citations55
US7091357B2Aug 15, 2006

Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies

UNIV KENTUCKY RES FOUND4 citations54
US7214710B2May 8, 2007

Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids

UNIV KENTUCKY RES FOUND0 citations51
US8703803B2Apr 22, 2014

Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors

UNIV KENTUCKY RES FOUND0 citations50

CROOKS PETER A

6 patents

UNIV KENTUCKY

5 patents

ALONSO ROBERT

4 patents

HOLTMAN JOSEPH R

3 patents

TARGACEPT INC

2 patents

ACTELION PHARMACEUTICALS LTD

2 patents

UNIV OF KENTUCKY

2 patents

YAUPON THERAPEUTICS INC

2 patents

JANGANATI VENUMADHAV

2 patents

SOUTHERN RES INST

1 patent

(unassigned)

1 patent

STINCHCOMB AUDRA L

1 patent

UNIV ARKANSAS

1 patent

Showing the top 50 of 54 patents by PatentIndex Score.